https://www.erdheim-chester.org/study_trials/dabrafenib-and-trametinib-in-treating-patients-with-erdheim-chester-disease-with-braf-v600-mutations/2020-11-03T14:48:56-06:00https://www.erdheim-chester.org/study_trials/a-safety-tolerability-and-pk-study-of-dcc-2618-in-patients-with-advanced-malignancies/2020-11-03T14:47:02-06:00https://www.erdheim-chester.org/study_trials/everolimus-and-anakinra-or-denosumab-in-treating-participants-with-relapsed-or-refractory-advanced-cancers/2019-11-12T09:29:51-06:00https://www.erdheim-chester.org/study_trials/a-study-of-plx8394-as-a-single-agent-in-patients-with-advanced-unresectable-solid-tumors/2019-11-12T09:29:11-06:00https://www.erdheim-chester.org/study_trials/phase-2-trial-of-single-agent-cobimetinib-for-adults-with-systemic-histiocytosis/2019-03-26T00:37:16-05:00https://www.erdheim-chester.org/study_trials/a-study-of-lenalidomide-for-adult-histiocyte-disorders/2019-11-12T09:25:16-06:00https://www.erdheim-chester.org/study_trials/clinical-and-pathophysiological-investigations-into-erdheim-chester-disease/2019-11-12T09:24:24-06:00https://www.erdheim-chester.org/study_trials/study-of-personalized-cancer-therapy-to-determine-response-and-toxicity-ucsd_predict/2019-11-12T09:23:55-06:00https://www.erdheim-chester.org/study_trials/international-rare-histiocytic-disorders-registry-irhdr/2019-03-26T01:10:52-05:00https://www.erdheim-chester.org/study_trials/observational-multi-center-study-on-erdheim-chester-disease-treated-with-anakinra/2019-03-26T01:21:21-05:00https://www.erdheim-chester.org/study_trials/long-term-outcome-after-vemurafenib-braf-inhibitors-interruption-in-erdheim-chester-disease-love/2019-03-26T01:39:54-05:00https://www.erdheim-chester.org/study_trials/histiocytic-neoplasms-biobank-and-database-lymphoma-specialized-programs-of-research-excellence-spore-09-2017-07-2022-and-lymphoma-epidemiology-of-outcomes-leo-cohort-study-leo/2021-09-27T13:35:47-05:00https://www.erdheim-chester.org/study_trials/a-study-of-memory-thinking-and-brain-imaging-in-adults-with-histiocytosis/2019-03-27T06:51:40-05:00https://www.erdheim-chester.org/study_trials/spit-for-a-cure-new-study-to-define-the-role-of-inheritance-in-histiocytic-diseases/2019-11-12T09:22:32-06:00https://www.erdheim-chester.org/study_trials/retrospective-review-of-patients-with-ecd-treated-with-interferon-alpha-or-imatinibmesylate/2019-11-12T09:22:05-06:00https://www.erdheim-chester.org/study_trials/developing-a-comprehensive-genomic-database-histiocytosis-research-laboratory/2019-11-12T09:21:01-06:00https://www.erdheim-chester.org/study_trials/hypoxia-and-inflammation-in-erdheim-chester-disease-microenvironment-insights-on-the-pathogenesis-and-implications-for-therapy/2019-03-27T08:40:26-05:00https://www.erdheim-chester.org/study_trials/understanding-dendritic-cell-lineages-in-erdheim-chester-disease-towards-a-non-invasive-diagnosis/2019-03-27T08:45:13-05:00https://www.erdheim-chester.org/study_trials/make-an-impact-tumor-gene-sequencing-for-ecd-patients-worldwide-at-memorial-sloan-kettering-cancer-center/2022-01-03T15:45:10-06:00https://www.erdheim-chester.org/study_trials/supportive-care-needs-of-caregivers-of-people-with-erdheim-chester-disease-and-other-histiocytic-diseases/2020-04-02T14:42:56-05:00https://www.erdheim-chester.org/study_trials/low-dose-selinexor-and-choline-salicylate-for-the-treatment-of-patients-with-residual-relapsed-or-refractory-non-hodgkin-lymphoma/2021-09-27T13:54:50-05:00https://www.erdheim-chester.org/study_trials/histiocytic-disorder-follow-up-study/2022-11-09T13:12:03-06:00